🔗 Permalink

Inventor profile of:

XI CHEN

City:

HOOVER, Alabama

Country:

United States

Published Applications:

Last publication date:

2022-10-06

Top Assignees for applications by XI CHEN

The entities that hold a legal rights for patent applications filed by inventor CHEN XI:

ADT Pharmaceuticals, LLC 10 Orange Beach, AL United States
JIANGSU MINGMA BIOTECH CO., LTD. 2 Taizhou, China
University of South Alabama 2 Mobile, AL United States
ADT PHARMACEUTICALS, INC. 2 Orange Beach, AL United States
Jiangsu Mingma Biotech Co., Ltd. 1 Taizhou City, China
Southern Research Institute Office of Commercialization and Intellectual Prop 1 Birmingham, AL United States

Recent patent applications by CHEN XI

XI CHEN from HOOVER, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-06

US20220315553A1

Chemistry; metallurgy

INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF

#2 | 2022-04-07

US20220106250A1

Chemistry; metallurgy

Derivatives of sulindac can protect normal cells against oxidative damage

#3 | 2022-02-17

US20220048931A1

Chemistry; metallurgy

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

#4 | 2021-08-26

US20210261572A1

Chemistry; metallurgy

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

#5 | 2020-07-16

US20200223817A1

Chemistry; metallurgy

Method of treating or preventing Ras-mediated diseases

#6 | 2020-07-16

US20200223816A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#7 | 2020-07-16

US20200223815A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#8 | 2020-03-26

US20200095184A1

Chemistry; metallurgy

Derivatives of sulindac can protect normal cells against oxidative damage

#9 | 2020-02-13

US20200048217A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#10 | 2020-01-30

US20200031795A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#11 | 2018-09-06

US20180251443A9

Chemistry; metallurgy

METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES

#12 | 2018-07-26

US20180208573A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#13 | 2018-02-15

US20180044314A1

Chemistry; metallurgy

Method of treating or preventing Ras-mediated diseases

#14 | 2017-11-30

US20170342021A1

Chemistry; metallurgy

RAS-INHIBITING INDENYL ACETAMIDE COMPOUNDS, COMPOSITIONS, AND USES

#15 | 2016-09-22

US20160273054A1

Chemistry; metallurgy

Serum/plasma MicroRNAs and uses thereof

#16 | 2016-06-23

US20160175275A1

Human necessities

Method of selectively inhibiting Ras-mediated tumor growth in humans

#17 | 2016-06-16

US20160168113A1

Chemistry; metallurgy

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#18 | 2016-06-16

US20160168108A1

Chemistry; metallurgy

METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES

#19 | 2014-05-01

US20140121133A1

Chemistry; metallurgy

Serum/plasma MicroRNAs and uses thereof

#20 | 2012-02-16

US20120040966A1

Chemistry; metallurgy

ANTI-VIRAL COMPOUNDS, TREATMENT, AND ASSAY

InventorID:

746237 ⎘